UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Abstract P1-11-04: Association between body mass index (BMI) and response to duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.P1-P1-11-04

2019

Volltextzugriff (PDF)

Abstract P5-15-02: Withdrawn

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.P5-P5-15-02

2018

Volltextzugriff (PDF)

Abstract GS4-04: Randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in women with early stage breast cancer (S1200)

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.GS4-04-GS4-04

2018

Volltextzugriff (PDF)

Abstract PD5-07: A phase III randomized trial of anastrozole and fulvestrant versus anastrozole or sequential anastrozole and fulvestrant as first-line therapy for postmenopausal women with metastatic breast cancer: Final survival outcomes of SWOG S0226

Cancer research (Chicago, Ill.), 2018-02, Vol.78 (4_Supplement), p.PD5-07-PD5-07

2018

Volltextzugriff (PDF)

Abstract S5-06: Randomized, placebo-controlled trial of duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) in early stage breast cancer (SWOG S1202)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.S5-S5-06

2017

Volltextzugriff (PDF)

Abstract OT1-03-11: Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor (HR) positive and HER2-negative breast cancer (BC): SWOG/NRG/Alliance S1207 (NCT01674140)

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.OT1-03-11-OT1-03-11

2016

Volltextzugriff (PDF)

Sequencing of Tamoxifen and Radiotherapy After Breast-Conserving Surgery in Early-Stage Breast Cancer

Journal of clinical oncology, 2005-01, Vol.23 (1), p.24-29

2005

Volltextzugriff (PDF)

Abstract P3-07-64: Association between gene variants in SULT1A1 and UGT1A4 and disease outcomes in patients enrolled in SWOG S0226 and treated with anastrozole alone or in combination with fulvestrant for metastatic breast cancer

Cancer research (Chicago, Ill.), 2016-02, Vol.76 (4_Supplement), p.P3-P3-07-64

2016

Volltextzugriff (PDF)

Abstract OT3-3-02: Phase IIB randomized double-blind placebo-controlled biomarker modulation study of high dose vitamin D in premenopausal women at high-risk for breast cancer: SWOG S0812

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.OT3-3-02-OT3-3-02

2013

Volltextzugriff (PDF)

Abstract OT2-2-04: A phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/− one year of everolimus in patients with high-risk, hormone receptor- (HR) positive and HER2-negative breast cancer: SWOG/NSABP S1207

Cancer research (Chicago, Ill.), 2012-12, Vol.72 (24_Supplement), p.OT2-2-04-OT2-2-04

2012

Volltextzugriff (PDF)

Abstract S5-07: SWOG S0500 – A randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (24_Supplement), p.S5-S5-07

2013

Volltextzugriff (PDF)

OT2-07-02: SWOG S0927: A Randomized Double Blind Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor (AI)-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.OT2-07-02-OT2-07-02

2011

Volltextzugriff (PDF)

S1-1: A Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First-Line Therapy for Postmenopausal Women with Metastatic Breast Cancer: SWOG S0226

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24_Supplement), p.S1-S1-1

2011

Volltextzugriff (PDF)

Sulforaphane-induced Cell Death in Human Prostate Cancer Cells Is Initiated by Reactive Oxygen Species

The Journal of biological chemistry, 2005-05, Vol.280 (20), p.19911-19924

2005

Volltextzugriff (PDF)

Beta-amino acids: versatile peptidomimetics

Current medicinal chemistry, 2002-04, Vol.9 (8), p.811-822

2002

Volltextzugriff (PDF)

Detailed assessment of global transport-energy models’ structures and projections

Transportation research. Part D, Transport and environment, 2017-08, Vol.55 (C), p.294-309

2017

Volltextzugriff (PDF)

Predictive value of somatosensory evoked potentials for awakening from coma

Critical care medicine, 2003-03, Vol.31 (3), p.960-967

2003

Volltextzugriff (PDF)

Construct validity for the LAPSIM laparoscopic surgical simulator

Surgical endoscopy, 2005-03, Vol.19 (3), p.401-405

2005

Volltextzugriff (PDF)

Predictive validity of driving-simulator assessments following traumatic brain injury: a preliminary study

Brain injury, 2005-03, Vol.19 (3), p.177-188

2005

Volltextzugriff (PDF)

Stepping over obstacles to improve walking in individuals with poststroke hemiplegia

Journal of rehabilitation research and development, 2004-05, Vol.41 (3A), p.283-292

2004

Volltextzugriff (PDF)

Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo

Carcinogenesis (New York), 2003-10, Vol.24 (10), p.1665-1670

2003

Volltextzugriff (PDF)

Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis

Journal of the American Academy of Dermatology, 1998-10, Vol.39 (4), p.590-596

1998

Volltextzugriff (PDF)

Entacapone improves motor fluctuations in levodopa- treated Parkinson's disease patients

Annals of neurology, 1997-11, Vol.42 (5), p.747-755

1997

Volltextzugriff (PDF)

Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report

Journal of the American Medical Informatics Association : JAMIA, 1998-05, Vol.5 (3), p.305-314

1998

Volltextzugriff (PDF)

Health state Preference assessment in diabetic peripheral neuropathy

PharmacoEconomics, 2002, Vol.20 (15), p.1079-1089

2002

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(44)
Buchkapitel
(1)

Sprache

Englisch
(45)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Abstract P1-11-04: Association between body mass index (BMI) and response to duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS)

Abstract P5-15-02: Withdrawn

Abstract GS4-04: Randomized blinded sham- and waitlist-controlled trial of acupuncture for joint symptoms related to aromatase inhibitors in women with early stage breast cancer (S1200)

Abstract PD5-07: A phase III randomized trial of anastrozole and fulvestrant versus anastrozole or sequential anastrozole and fulvestrant as first-line therapy for postmenopausal women with metastatic breast cancer: Final survival outcomes of SWOG S0226

Abstract S5-06: Randomized, placebo-controlled trial of duloxetine for aromatase inhibitor (AI)-associated musculoskeletal symptoms (AIMSS) in early stage breast cancer (SWOG S1202)

Abstract OT1-03-11: Phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/- one year of everolimus in patients with high-risk, hormone receptor (HR) positive and HER2-negative breast cancer (BC): SWOG/NRG/Alliance S1207 (NCT01674140)

Sequencing of Tamoxifen and Radiotherapy After Breast-Conserving Surgery in Early-Stage Breast Cancer

Abstract P3-07-64: Association between gene variants in SULT1A1 and UGT1A4 and disease outcomes in patients enrolled in SWOG S0226 and treated with anastrozole alone or in combination with fulvestrant for metastatic breast cancer

Abstract OT3-3-02: Phase IIB randomized double-blind placebo-controlled biomarker modulation study of high dose vitamin D in premenopausal women at high-risk for breast cancer: SWOG S0812

Abstract OT2-2-04: A phase III randomized, placebo-controlled clinical trial evaluating the use of adjuvant endocrine therapy +/− one year of everolimus in patients with high-risk, hormone receptor- (HR) positive and HER2-negative breast cancer: SWOG/NSABP S1207

Abstract S5-07: SWOG S0500 – A randomized phase III trial to test the strategy of changing therapy versus maintaining therapy for metastatic breast cancer patients who have elevated circulating tumor cell (CTC) levels at first follow-up assessment

OT2-07-02: SWOG S0927: A Randomized Double Blind Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor (AI)-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer

S1-1: A Phase III Randomized Trial of Anastrozole Versus Anastrozole and Fulvestrant as First-Line Therapy for Postmenopausal Women with Metastatic Breast Cancer: SWOG S0226

Sulforaphane-induced Cell Death in Human Prostate Cancer Cells Is Initiated by Reactive Oxygen Species

Beta-amino acids: versatile peptidomimetics

Detailed assessment of global transport-energy models’ structures and projections

Predictive value of somatosensory evoked potentials for awakening from coma

Construct validity for the LAPSIM laparoscopic surgical simulator

Predictive validity of driving-simulator assessments following traumatic brain injury: a preliminary study

Stepping over obstacles to improve walking in individuals with poststroke hemiplegia

Allyl isothiocyanate, a constituent of cruciferous vegetables, inhibits growth of PC-3 human prostate cancer xenografts in vivo

Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis

Entacapone improves motor fluctuations in levodopa- treated Parkinson's disease patients

Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary report

Health state Preference assessment in diabetic peripheral neuropathy

Suchergebnisse filtern